← Back to Search

Heart Health Assessment Tool for Endometrial Cancer Survivors

N/A

Waitlist Available

Led By Kathryn E Weaver, PhD, MPH

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial aims to improve heart health for cancer patients by asking them to use an electronic tool. Researchers hope to learn how to better help patients manage their heart health. #HeartHealth #CancerCare

Who is the study for?

This trial is for endometrial cancer survivors who are at least 18 years old, can read medical information in English, have an email address, and are more than 3 months post-cancer treatment. They should be scheduled for a routine check-up but not currently receiving cancer treatments or expected to live less than six months.Check my eligibility

What is being tested?

The study tests a digital tool called the PREVENT Cardiovascular Health Assessment Tool along with surveys and interviews about heart health. It aims to understand how this tool might help manage heart health for cancer survivors outside of clinical settings.See study design

What are the potential side effects?

Since this trial involves using an assessment tool and providing feedback rather than testing a drug or medical procedure, there are no direct physical side effects associated with participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants to Complete Heart Health Assessment - Feasibility

Secondary outcome measures

Number of Participants Stating Satisfaction with PREVENT Tool

Number of Participants to Report Initiating Discussions Regarding Cardiovascular Health with Health Care Providers

Trial Design

1Treatment groups

Experimental Treatment

Group I: PREVENT - Cardiovascular Health Assessment ToolExperimental Treatment3 Interventions

An adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,239 Previous Clinical Trials

1,004,141 Total Patients Enrolled

1 Trials studying Endometrial Cancer

112 Patients Enrolled for Endometrial Cancer

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,111 Total Patients Enrolled

74 Trials studying Endometrial Cancer

73,332 Patients Enrolled for Endometrial Cancer

Kathryn E Weaver, PhD, MPHPrincipal InvestigatorWake Forest Baptist Comprehensive Cancer Center

Media Library

PREVENT - Cardiovascular Health Assessment Tool Clinical Trial Eligibility Overview. Trial Name: NCT05796518 — N/A

Endometrial Cancer Research Study Groups: PREVENT - Cardiovascular Health Assessment Tool

Endometrial Cancer Clinical Trial 2023: PREVENT - Cardiovascular Health Assessment Tool Highlights & Side Effects. Trial Name: NCT05796518 — N/A

PREVENT - Cardiovascular Health Assessment Tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT05796518 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there current openings for participants in this research project?

"As noted on clinicaltrials.gov, the timelines for this medical trial indicate that it is not currently open to new patients. This study was first posted June 1st 2023 and the last update took place March 21st 2023. Additionally, there are 340 other studies actively seeking participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

2023. "Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05796518.